Bcl10 Recombinant Rabbit mAb
Cat No.: ARM1365
Size：
| Product Name: | Bcl10 Recombinant Rabbit mAb |
| Cat No.: | ARM1365 |
| source: | Rabbit |
| reactivity: | Human |
| applications: | WB,FC |
| clonality: | Monoclonal |
| recommended dilution: | WB,FC |
| format: | Liquid |
| isotype: | IgG |
| immunogen: | A synthetic peptide of human Bcl10 |
| calculated molecular weight: | 26 kDa |
| observed molecular weight: | 26 kDa |
| genbank accession number: | O95999 |
| gene id (ncbi): | 8915 |
| purification method: | Affinity Purification |
| conjugate: | Un-conjugated |
| storage: | Store at -20°C. Supplied in 50nM Tris-Glycine(pH 7.4), 0.15M NaCl, 40%Glycerol, 0.01% sodium azide and 0.05% BSA. Stable for 12 months from date of receipt. |
| synonyms: | CLAP; mE10; CIPER; IMD37; c-E10; CARMEN |
| category: | Primary Ab |
| concentration: | 1mg/ml |
| background: | This gene was identified by its translocation in a case of mucosa-associated lymphoid tissue (MALT) lymphoma. The protein encoded by this gene contains a caspase recruitment domain (CARD), and has been shown to induce apoptosis and to activate NF-kappaB. This protein is reported to interact with other CARD domain containing proteins including CARD9, 10, 11 and 14, which are thought to function as upstream regulators in NF-kappaB signaling. This protein is found to form a complex with MALT1, a protein encoded by another gene known to be translocated in MALT lymphoma. MALT1 and this protein are thought to synergize in the activation of NF-kappaB, and the deregulation of either of them may contribute to the same pathogenetic process that leads to the malignancy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2016] |